Abstract
There is strong evidence supporting the use of low-dose aspirin in the secondary prevention of cardiovascular events in patients with type 2 diabetes but the evidence is less robust in primary prevention. Also, aspirin use can be associated with serious gastrointestinal haemorrhage.
| Original language | English |
|---|---|
| Pages (from-to) | 44-47 |
| Number of pages | 4 |
| Journal | Medicine Today |
| Volume | 13 |
| Issue number | 1 |
| Publication status | Published or Issued - Jan 2012 |
| Externally published | Yes |
ASJC Scopus subject areas
- General Medicine